Understanding how mitochondria change with age could eventually help veterinarians better prevent, manage, and treat age-related health problems in senior horses.
In a recent study, the SGLT2 inhibitor canagliflozin showed promise as an adjunct treatment for reducing hyperinsulinemia in horses with insulin dysregulation.
